Matches in Nanopublications for { ?s ?p "[Despite an initial response to EGFR tyrosine kinase inhibitors (EGFR-TKI) in EGFR mutant lung cancer, most patients eventually become resistant and result in treatment failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP178114.RAOuoAexAKYP_ZvsrfWmhKooxkIr0dHSCT8T7se39X4ME130_assertion description "[Despite an initial response to EGFR tyrosine kinase inhibitors (EGFR-TKI) in EGFR mutant lung cancer, most patients eventually become resistant and result in treatment failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP178114.RAOuoAexAKYP_ZvsrfWmhKooxkIr0dHSCT8T7se39X4ME130_provenance.
- NP947094.RAM-l5dTgM-tqsSYj9qv96fuEGvQwrC7mW7-qcAfhrKl4130_assertion description "[Despite an initial response to EGFR tyrosine kinase inhibitors (EGFR-TKI) in EGFR mutant lung cancer, most patients eventually become resistant and result in treatment failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947094.RAM-l5dTgM-tqsSYj9qv96fuEGvQwrC7mW7-qcAfhrKl4130_provenance.
- NP947097.RAI6n5IzxVxyDRzfx_UNryRqW7264Mt1y5IWXSVVLBNmI130_assertion description "[Despite an initial response to EGFR tyrosine kinase inhibitors (EGFR-TKI) in EGFR mutant lung cancer, most patients eventually become resistant and result in treatment failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947097.RAI6n5IzxVxyDRzfx_UNryRqW7264Mt1y5IWXSVVLBNmI130_provenance.